BINSA Act

This bill would add biotechnology to the list of technologies covered by federal rules that screen U.S. investments in certain foreign countries, such as China. Biotechnology would cover the research, development, making, or sale of drugs, biological products, and therapeutic compounds, including drug discovery platforms and related know-how. The bill would also treat licensing a prohibited technology from a covered foreign person as a covered transaction. The Treasury Secretary would have one year to issue a rule defining biotechnology for these purposes, excluding agricultural biotechnology and basic academic research with no direct drug use. The Defense Secretary would have 60 days to report to Congress on whether U.S. money flowing into China's biotechnology sector affects national security and military readiness.

Full text and official record on Congress.gov

Sponsors

• John R. Moolenaar Republican sponsor
• 1 cosponsors